scholarly article | Q13442814 |
P50 | author | Maurizio Inghilleri | Q42770750 |
Marco Ceccanti | Q56965348 | ||
Emanuela Onesti | Q88803974 | ||
Vittorio Frasca | Q114420070 | ||
Chiara Cambieri | Q114420077 | ||
P2093 | author name string | Giovanni Ruoppolo | |
Ilenia Schettino | |||
Maria Cristina Gori | |||
P2860 | cites work | Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) | Q24201081 |
A penetration-aspiration scale | Q28285311 | ||
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
The Pooling-score (P-score): inter- and intra-rater reliability in endoscopic assessment of the severity of dysphagia | Q33628512 | ||
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). | Q33909851 | ||
Partial block by riluzole of muscle sodium channels in myotubes from amyotrophic lateral sclerosis patients. | Q34755164 | ||
Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? | Q35590266 | ||
Diagnostic investigation and multidisciplinary management in motor neuron disease | Q36346085 | ||
Electrodiagnostic criteria for diagnosis of ALS. | Q37046933 | ||
Pooling score: an endoscopic model for evaluating severity of dysphagia. | Q37102769 | ||
Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis | Q37193625 | ||
Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China | Q37359581 | ||
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology | Q37613342 | ||
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force | Q37931374 | ||
Nutritional and metabolic support in patients with amyotrophic lateral sclerosis | Q38017023 | ||
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis | Q38541904 | ||
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study | Q41531607 | ||
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre | Q43795777 | ||
Management of dysphagia in Parkinson's disease and amyotrophic lateral sclerosis | Q44313745 | ||
Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings. | Q44670624 | ||
Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best". | Q47573938 | ||
Prognosis in amyotrophic lateral sclerosis: a population-based study. | Q51950008 | ||
Afferent nerve ending density in the human laryngeal mucosa: potential implications on endoscopic evaluation of laryngeal sensitivity. | Q53358692 | ||
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). | Q53535985 | ||
Amyotrophic lateral sclerosis | Q55877676 | ||
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study | Q60464524 | ||
Prevention of barium aspiration during videofluoroscopic swallowing studies: value of change in posture | Q70654032 | ||
Predictability of disease progression in amyotrophic lateral sclerosis | Q80246453 | ||
Management of symptoms in amyotrophic lateral sclerosis | Q80852665 | ||
Amyotrophic lateral sclerosis: sonographic evaluation of dysphagia | Q82992070 | ||
[Analysis of oropharyngeal phase of swallowing in patients with amyotrophic lateral sclerosis] | Q83363473 | ||
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival | Q83523647 | ||
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
dysphagia | Q623289 | ||
P304 | page(s) | 94 | |
P577 | publication date | 2017-03-21 | |
P1433 | published in | Frontiers in Neurology | Q15817039 |
P1476 | title | Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management | |
P478 | volume | 8 |
Q59135014 | Analysis of riluzole’s profile of use in a Central Hospital in Lisbon |
Q64228443 | Clinical Measures of Bulbar Dysfunction in ALS |
Q89775631 | Evaluation and Management of Dysphagia in Amyotrophic Lateral Sclerosis: A Survey of Speech-Language Pathologists' Clinical Practice |
Q57467373 | Functional and Endoscopic Indicators for Percutaneous Endoscopic Gastrostomy (PEG) in Amyotrophic Lateral Sclerosis Patients |
Q57465334 | Hypoglossal Motor Neuron Death Via Intralingual CTB-saporin (CTB-SAP) Injections Mimic Aspects of Amyotrophic Lateral Sclerosis (ALS) Related to Dysphagia |
Q58787868 | Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives |
Q90264194 | Taste changes in amyotrophic lateral sclerosis and effects on quality of life |